drugset / Trial / NCT03513874
Metformin Plus Insulin on Non-obese Autoimmune Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the therapeutic effect of metformin as additional treatment with insulin on non-obese autoimmune diabetes.
Timeline
- Start
- 2017-08-01
- Primary completion
- 2020-12-31
- Completion
- 2021-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 850 mg | Oral |
| Background | Insulin | Protein / enzyme biologic | — | — |